These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26215834)

  • 1. The Role of PGRN in Alzheimer's Disease.
    Jing H; Tan MS; Yu JT; Tan L
    Mol Neurobiol; 2016 Aug; 53(6):4189-4196. PubMed ID: 26215834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.
    Takahashi H; Klein ZA; Bhagat SM; Kaufman AC; Kostylev MA; Ikezu T; Strittmatter SM;
    Acta Neuropathol; 2017 May; 133(5):785-807. PubMed ID: 28070672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.
    Minami SS; Min SW; Krabbe G; Wang C; Zhou Y; Asgarov R; Li Y; Martens LH; Elia LP; Ward ME; Mucke L; Farese RV; Gan L
    Nat Med; 2014 Oct; 20(10):1157-64. PubMed ID: 25261995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease.
    Van Kampen JM; Kay DG
    PLoS One; 2017; 12(8):e0182896. PubMed ID: 28837568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progranulin haploinsufficiency reduces amyloid beta deposition in Alzheimer's disease model mice.
    Hosokawa M; Tanaka Y; Arai T; Kondo H; Akiyama H; Hasegawa M
    Exp Anim; 2018 Feb; 67(1):63-70. PubMed ID: 28845019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology.
    Mendsaikhan A; Tooyama I; Bellier JP; Serrano GE; Sue LI; Lue LF; Beach TG; Walker DG
    Acta Neuropathol Commun; 2019 Dec; 7(1):215. PubMed ID: 31864418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases.
    Mendsaikhan A; Tooyama I; Walker DG
    Cells; 2019 Mar; 8(3):. PubMed ID: 30862089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin and beta-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier.
    Gliebus G; Rosso A; Lippa CF
    Am J Alzheimers Dis Other Demen; 2009 Dec-2010 Jan; 24(6):456-60. PubMed ID: 19776335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin Levels.
    Mason AR; Elia LP; Finkbeiner S
    J Biol Chem; 2017 Feb; 292(8):3262-3272. PubMed ID: 28069809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progranulin and Amyloid-β Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease.
    Körtvélyessy P; Gukasjan A; Sweeney-Reed CM; Heinze HJ; Thurner L; Bittner DM
    J Alzheimers Dis; 2015; 46(2):375-80. PubMed ID: 25777512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prosaposin is a regulator of progranulin levels and oligomerization.
    Nicholson AM; Finch NA; Almeida M; Perkerson RB; van Blitterswijk M; Wojtas A; Cenik B; Rotondo S; Inskeep V; Almasy L; Dyer T; Peralta J; Jun G; Wood AR; Frayling TM; Fuchsberger C; Fowler S; Teslovich TM; Manning AK; Kumar S; Curran J; Lehman D; Abecasis G; Duggirala R; Pottier C; Zahir HA; Crook JE; Karydas A; Mitic L; Sun Y; Dickson DW; Bu G; Herz J; Yu G; Miller BL; Ferguson S; Petersen RC; Graff-Radford N; Blangero J; Rademakers R
    Nat Commun; 2016 Jun; 7():11992. PubMed ID: 27356620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
    J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.
    Morenas-Rodríguez E; Cervera-Carles L; Vilaplana E; Alcolea D; Carmona-Iragui M; Dols-Icardo O; Ribosa-Nogué R; Muñoz-Llahuna L; Sala I; Belén Sánchez-Saudinós M; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2016; 50(2):539-46. PubMed ID: 26682689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice.
    Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
    Neuroscience; 2013 Oct; 250():8-19. PubMed ID: 23830905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice.
    Hosokawa M; Arai T; Masuda-Suzukake M; Kondo H; Matsuwaki T; Nishihara M; Hasegawa M; Akiyama H
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):158-65. PubMed ID: 25575133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.
    Xin SH; Tan L; Cao X; Yu JT; Tan L
    Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progranulin peripheral levels as a screening tool for the identification of subjects with progranulin mutations in a Portuguese cohort.
    Almeida MR; Baldeiras I; Ribeiro MH; Santiago B; Machado C; Massano J; Guimarães J; Resende Oliveira C; Santana I
    Neurodegener Dis; 2014; 13(4):214-23. PubMed ID: 24022032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.
    Hensley K; Kursula P
    J Alzheimers Dis; 2016 Apr; 53(1):1-14. PubMed ID: 27079722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.